• Lung Transplantation

    How to Qualify Lung Transplant Considerations Lung Transplant Manuals, Guides, Videos and more

  • Provincial Resources

    Find resources in each province for pulmonary fibrosis medical care and support.

  • Antifibrotic Medication Monographs

    Detailed product monograph for OFEV (updated 2021) Detailed product monograph for Esbriet (updated 2021)

  • Patient Information Leaflets (PILs)

    Nintedanib (OFEV) Pirfenidone (Esbriet)

  • Drug Coverage by Province

    Explore drug coverage for each province and territory in Canada

  • 2023

    Dec 2023Integration and Application of Radiologic Patterns From Clinical Practice Guidelines on Idiopathic Pulmonary Fibrosis and Fibrotic Hypersensitivity Pneumonitis Early versus late onset interstitial lung disease in rheumatoid arthritis: An […]

  • 2022

    November 2022Pregnancy Considerations for Patients With Interstitial Lung Disease August 2022Perceptions of Genetic Testing: A Mixed-Methods Study of Patients with Pulmonary Fibrosis and Their First-Degree Relatives Interstitial Lung Disease in […]

  • 2021

    December 2021Malignancy Risk Associated with the use of Mycophenolate Mofetil in Interstitial Lung Disease September 2021Extracellular Heat Shock Proteins as Therapeutic Targets and Biomarkers in Fibrosing Interstitial Lung Diseases August […]

  • 2020

    September 2020Frailty in patients with interstitial lung disease Long-term monitoring of patients with fibrotic interstitial lung disease: A Canadian Thoracic Society position statement August 2020Sputum quantitative cytometry in patients with […]